LX-22001

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameLX-22001
Drug Alias NameLX22001LX-22001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockers
TargetsPotassium channel
Therapy Area/IndicationsHemorrhageDuodenal UlcerPeptic Ulcer Hemorrhage +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShandong Luoxin Pharmaceutical Group Stock Co LtdLuoxin Pharmaceutical (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLuoxin Pharmaceutical (Shanghai) Co LtdShandong Luoxin Pharmaceutical Group Stock Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhageDuodenal UlcerPeptic Ulcer Hemorrhage +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A